Can population pharmacokinetic modelling guide vancomycin dosing during continuous renal replacement therapy in critically ill patients?
Andrew Udy(The Alfred Hospital), Jason A. Roberts(Queensland Health), Fabio Silvio Taccone(Université Libre de Bruxelles), Jean‐Louis Vincent(Université Libre de Bruxelles), Jeffrey Lipman(Queensland Health), Cecilia Covajes(Université Libre de Bruxelles), Frédérique Jacobs(Université Libre de Bruxelles)
Cited by 54
Related Papers
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
|JAMA|2016|28.1k
The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure
|Intensive Care Medicine|1996|11.7k
Surviving Sepsis Campaign
|Critical Care Medicine|2013|9.7k
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012
|Intensive Care Medicine|2013|7.3k
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
|New England Journal of Medicine|2001|6.1k